Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation.
about
Use of rifaximin in gastrointestinal and liver diseasesNew and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologistsPregnane X receptor as a target for treatment of inflammatory bowel disordersFXR signaling in the enterohepatic systemSustained Isoprostane E2 Elevation, Inflammation and Fibrosis after Acute Ischaemia-Reperfusion Injury Are Reduced by Pregnane X Receptor ActivationPXR variants: the impact on drug metabolism and therapeutic responsesAlleviation of gut inflammation by Cdx2/Pxr pathway in a mouse model of chemical colitisNovel functions of PXR in cardiometabolic disease.Role of human pregnane X receptor in high fat diet-induced obesity in pre-menopausal female mice.Marine and semi-synthetic hydroxysteroids as new scaffolds for pregnane X receptor modulationActivation of intestinal human pregnane X receptor protects against azoxymethane/dextran sulfate sodium-induced colon cancerCurrent and emerging drugs for the treatment of inflammatory bowel disease.Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activationPregnane X receptor- and CYP3A4-humanized mouse models and their applications.Post-translational modification of pregnane x receptor.Intestinal pregnane X receptor links xenobiotic exposure and hypercholesterolemia.Review article: the potential mechanisms of action of rifaximin in the management of inflammatory bowel diseases.Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approachSmall-molecule modulators of PXR and CAR.Decreased Pregnane X Receptor Expression in Children with Active Crohn's Disease.Rifaximin for the treatment of irritable bowel syndrome - a drug safety evaluation.Rifaximin is an effective alternative to metronidazole for the treatment of chronic enteropathy in dogs: a randomised trial.Tanshinone IIA ameliorates dextran sulfate sodium-induced inflammatory bowel disease via the pregnane X receptor.Chronic exposure to rifaximin causes hepatic steatosis in pregnane X receptor-humanized micePXR antagonists and implication in drug metabolism.Chrysin ameliorates chemically induced colitis in the mouse through modulation of a PXR/NF-κB signaling pathwayRifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain.Protective effect of naringenin against experimental colitis via suppression of Toll-like receptor 4/NF-κB signallingSolomonsterol A, a marine pregnane-X-receptor agonist, attenuates inflammation and immune dysfunction in a mouse model of arthritis.Targeting nuclear receptors with marine natural products.Challenges and opportunities of metabolomics.Xenobiotic receptor humanized mice and their utility.PXR cross-talks with internal and external signals in physiological and pathophysiological responses.Pregnane X receptor polymorphisms associated with human diseases.LC-MS-based metabolomics: an update.Rifaximin: beyond the traditional antibiotic activity.Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.Rifamycins, Alone and in Combination.Identification of three novel natural product compounds that activate PXR and CAR and inhibit inflammationMolecular docking to understand the metabolic behavior of GNF-351 by CYP3A4 and its potential drug-drug interaction with ketoconazole.
P2860
Q26740201-020FE6AA-378E-4C4A-B141-A0BD1B618D5EQ26748617-A44D4557-DCEE-4887-ABFC-9ECA6553A24BQ26998347-F945017F-B27C-4CFD-9DA0-E411E67A2A6FQ27014753-32D57589-3F17-4109-8250-D7C4E529564FQ27322581-3D948211-F29A-43AE-8936-E1E08114220FQ28080023-87509053-25D2-492B-B137-462B13311E02Q28481350-6FBDC584-C419-421C-A796-F5264C3851F3Q30251861-818F1E5B-82D2-4320-A5A2-31B0E190FDB1Q33756030-3144A955-F7FC-4497-A051-DC37A4B10BF4Q33808887-3F5FF0FE-8B9C-434A-94FD-DA97A763AE3BQ34573895-1D52031E-5F44-4866-8385-9A4F99DAA89DQ34883210-93570577-8977-4EAC-A103-51116A934171Q34946639-FA31E1BA-5F8D-441A-8CC4-95B73C348300Q35005644-17B46A97-2D76-4073-9060-F090942635ABQ35034168-729EEB43-DBF1-462E-AB9A-80C7A25DC01AQ35555694-6D2AF4FA-B3DB-4F29-B929-35BC65419636Q35855737-EC492FBD-F42B-4A9B-9033-8B8793103332Q35870133-53C96879-7CBC-4191-A0C2-720E8008CC1EQ35938150-BFC06691-26E6-43BE-B7D8-CA020B0E44B5Q35969912-286CFA5B-EF6D-40EF-8EA7-3DED09F92687Q36009729-A7BE784F-083D-459E-B8DA-C10F5AAAD83CQ36157264-1407E613-060C-4FD7-9C77-2F0CCC6679DBQ36365170-565F8CD5-988A-4CE0-9F0B-88553684C7EFQ36379917-9FE7B9AF-CAE4-47DF-BE69-CE8C8852E2F0Q36640752-F5435934-62F3-4036-AA08-E81BE6D6077BQ36852609-9FEBAC14-1FBD-4EBF-8A7D-EFE278566297Q36945155-B9BB706A-9E93-465A-A96D-855AB540F941Q37053805-A6F69BF9-11A7-40A5-82B8-9B39657CE136Q37566161-B2EEC454-CFD5-479C-B378-C89724A3856CQ37621100-8EA78B37-ECF3-4646-B8A4-A4D0F9365803Q37950296-51A7F636-B04A-4BEB-81F4-088E38B32DA0Q38061645-F766BEA8-8EAF-494E-9571-B19567A837FFQ38108791-AB25579F-D39D-45C2-930B-4C548E28B3ACQ38138603-16F9C91A-3595-41B9-8CAB-ADFECAED3BE1Q38202881-A4E4FE26-3C62-4FB0-901A-63891CFC7ADBQ38237218-F4B3175B-BE83-42EB-B9B9-BF00988D8E1AQ38692607-90BDB782-E423-4714-8D0F-B153078B3C87Q38857578-D5382E4A-CF1A-4AF5-9528-E76BBBA79243Q39118521-AD7408F6-2090-4CD5-8C96-7819DF78E4CCQ39205301-5436D69A-3799-48B9-BA5B-1D129397153C
P2860
Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Therapeutic role of rifaximin ...... regnane X receptor activation.
@ast
Therapeutic role of rifaximin ...... regnane X receptor activation.
@en
Therapeutic role of rifaximin ...... regnane X receptor activation.
@nl
type
label
Therapeutic role of rifaximin ...... regnane X receptor activation.
@ast
Therapeutic role of rifaximin ...... regnane X receptor activation.
@en
Therapeutic role of rifaximin ...... regnane X receptor activation.
@nl
prefLabel
Therapeutic role of rifaximin ...... regnane X receptor activation.
@ast
Therapeutic role of rifaximin ...... regnane X receptor activation.
@en
Therapeutic role of rifaximin ...... regnane X receptor activation.
@nl
P2093
P2860
P356
P1476
Therapeutic role of rifaximin ...... regnane X receptor activation.
@en
P2093
Frank J Gonzalez
Kristopher W Krausz
Tatsuhiko Kodama
Toshiya Tanaka
Xiaochao Ma
Xiaoyan Pang
Yatrik M Shah
P2860
P356
10.1124/JPET.110.170225
P407
P577
2010-07-13T00:00:00Z